Back to top
more

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

T Rowe Price Health Sciences Fd: (MF: PRHSX)

(MF) As of Aug 27, 2015 06:05 PM ET

 Add to portfolio

$79.35 USD

+1.69 (2.18%)

Zacks MF Rank : 2 - Buy [?]   2      

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Jul 31, 2015

Total Return %* Percentile Rank Objective
YTD 23.54 23
3 months 11.48 26
6 months 18.44 28
1 Year 46.05 25
3 Year 37.21 25
5 Year 34.02 15
10 Year 18.86 3

* Annual for three years and beyond.

Zacks Premium Research for PRHSX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank [?] Buy 2
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 43.04
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 7/31/2015 11,770.00
%Turnover 7/31/2015 42.20

Risk

3 Year 5 Year 10 Year
Beta 0.85 0.91 0.86
Alpha 20.35 17.48 11.56
R Squared 0.30 0.54 0.62
Std. Dev. 13.24 14.51 16.24
Sharpe 2.89 2.43 1.00

Sector / Country Weightings

As of 7/31/2015 % of Portfolio
Health 52.70
Other 14.55
Finance 12.31
Services 8.03
Retail Trade 5.31
Industrial Cyclical 3.69
Technology 2.82
Non-Durable 0.59

Portfolio Holdings

Top Equity Holdings
(As of 3/31/2015)
% of Portfolio Value (Mil$)
ACTAVIS INC 5.33 766.06
PHARMACYCLICS INC 3.76 540.85
GILEAD SCIENCES INC 3.60 516.67
VALEANT PHARMACEUTICALS 3.53 507.40
ALEXION PHARMACEUTICALS I 3.41 489.45
MCKESSON CORP 3.21 460.75
AETNA INC 3.10 446.00
UNITEDHEALTH GROUP INC 2.91 417.75
BIOGEN INC 2.36 338.85

Stock Holding % of Net Assets

As Of 3/31/2015
Total Issues 148
Avg. P/E 21.56
Avg. P/Book 4.44
Avg. EPS Growth 11.45
Avg. Market Value (Mil $) 39,692

Allocation

% of Portfolio
Large Growth 25.29
Large Value 0.00
Small Growth 47.26
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00